UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT TO~~Pursuant ~~SECTION~~to Section 13 ORor 15(Dd) OFof ~~THE~~the

~~SECURITIES EXCHANGE~~Securities ~~ACT~~Exchange OFAct of 1934

~~August 23,~~Date ~~2005~~of Report (~~August~~Date ~~19,~~of ~~2005~~earliest event reported): June 3, 2010

Date of Report (Date of earliest event reported):

Imagin Molecular Corporation

(Exact name of ~~Registrant~~registrant as specified in its ~~Charter~~charter)

(formerly known as)

Delaware	000-29449	13-4099008
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

~~Cipher Holding~~3 ~~Corporation~~Grant Square, #315, Hinsdale, Illinois 60521

~~Delaware 0-23873 13-4099008~~(Address of principal executive office, including zip code)

(~~State or other jurisdiction (Commission File Number~~630) ~~(IRS Employer~~ 230-8734

~~Identification Number~~(Telephone number, including area code)

Delaware	0-23873	13-4099008
(State or other jurisdiction)	(Commission File Number)	(IRS Employer Identification Number)

3801 N. Washington Street

Oak Brook, Illinois 60523

(Address of Principal Executive Office)

Registrant’s telephone number, including area code: (630) 371-5583

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Section~~ Item 5 ~~Corporate Governance~~.02 Departure ~~and~~of ~~Management~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Agreements of Certain Officers.

~~Item 5~~On June 3, 2010, Joseph G.~~02 Departure~~ Oliverio resigned as Director and Chief Executive Officer of ~~Directors~~the orRegistrant, ~~Principal~~Corey ~~Officers;~~Conn ~~Election~~resigned as Director and Chief Financial Officer of ~~Directors;~~the Registrant and Neil Sy resigned as Director of the Registrant.

~~Appointment~~ On June 3, 2010, Patrick J. Rooney, Ghassan Barazi and Nicholas Anthony Havercroft were elected and appointed to the Board of ~~Principal~~Directors ~~officers~~of the Registrant. Also on that date, Mr. Rooney was appointed Director of Corporate Development and Mr. Barazi was appointed the Registrant’s President.

OnPatrick ~~August 19~~J. Rooney, ~~2005~~70, ~~Patrick~~Chairman Gand Director of Corporate Development. Mr. Rooney, is a co-founder of the ~~Registrant’s~~Planet ~~Chairman,~~Green ~~President~~Bottle Corporation and ~~Chief Executive~~has ~~officer~~served ~~resigned~~as ~~from~~its ~~those~~Director ~~positions.~~of ~~Upon~~Corporate ~~unanimous~~Development ~~consent~~since of2008. Simultaneously ~~the Board~~therewith ofand ~~Directors~~since 2004, ~~the~~Mr. ~~position~~Rooney has served as Director of ~~Chairman~~Corporation ~~was~~Development ~~filled~~for byIMAGIN ~~Neil~~Diagnostic SyCentres, ~~who~~Inc. ~~was~~(“IDC”) ~~also appointed~~a ~~the~~Canadian ~~Registrant’s~~company ~~President~~which is a pioneer in imaging-based cancer, cardiac and ~~Chief~~neurological ~~Financial~~disease ~~Officer~~diagnosis. Mr. ~~Corey~~Rooney ~~Conn~~became CEO and sole director of IDC in February, 2007. Patrick Rooney has a ~~Director~~ long career of ~~the~~founding ~~Registrant,~~and ~~vacated~~funding early stage technology-based medical and environmental companies that have a purpose of making a contribution to the ~~position~~health and well-being of ~~Chief~~society. Historically ~~Financial~~Mr. ~~Officer~~Rooney has completed approximately 150 initial public offering (IPO’s) and /or reverse mergers. Mr. Rooney was ~~appointed~~the control shareholder and CEO of an office services company Services Resources Corporation (name changed to ~~serve~~Ameriscribe) aswhose shares were listed on the ~~Registrant’s~~N.Y.S.E. ~~Chief~~and ~~Executive~~was ~~Officer~~sold to Pitney Bowes.

~~Neil~~On ~~Sy, 37,~~September ~~President~~27, ~~Chief~~2007 ~~Financial~~the ~~Officer,~~Ontario isSecurities ~~currently~~Commission ~~engaged~~alleged that Mr. Rooney and IDC traded in ~~capital~~securities ~~raising ventures~~of ~~including~~IDC ~~consumer~~without ~~medicine~~registration. Mr. Rooney and ~~real~~IDC ~~estate~~have ~~properties~~opposed inthe ~~Chicago~~allegation. After a hearing, ~~Illinois~~ ~~and~~a ~~Las~~decision ~~Vegas~~has not yet been rendered by the OSC. In 1987, ~~Nevada~~Mr. ~~Prior~~Rooney ~~thereto~~was charged by the United States with tax evasion and ~~from~~signing ~~1997~~a tofalse ~~2003,~~tax return for taxes due for the taxable year 1983. At trial Mr. SyRooney was a ~~member~~acquitted of ~~the~~tax ~~Chicago~~evasion ~~Board~~and ~~Options~~convicted ~~Exchange~~of assigning a ~~market~~false ~~maker~~tax return. The ~~Prior~~amount ~~thereto~~of tax unpaid as calculated on his 1983 tax return charged in the offence was $9, 000. Mr. Rooney paid taxes in excess of $800,000 in 1983 and ~~from~~it ~~1992~~was todemonstrated ~~1997~~at trial that Mr. Rooney in fact overpaid his 1983 taxes therefore an acquittal for tax evasion resulted. In 2001, Mr. SyRooney ~~worked~~settled ona ~~the~~civil ~~Chicago~~case ~~Board~~with ~~Options~~the Securities and Exchange Commission on alleged insider trading, without denying or admitting wrongdoing and agreed not to conduct activities paramount to operating as a ~~trade~~ ~~manager~~broker/dealer. Mr. SyRooney ~~received~~agreed to a ~~Bachelor’s~~settlement ~~Degree~~which inincluded ~~Business~~return ~~Administration from~~of ~~Southern~~profits ~~Illinois~~and ~~University~~penalties in an amount of $1,800,000.

Ghassan Barazi, 46, President, Director. Since 2007, Mr. Barazi has served as the CEO of CARE Imaging Centres, and CI Pharma, both companies involved in performing PET (positron emission tomography) scans for cancer patients. Mr. Barazi, a mechanical engineer, started his career when he formed Cad Venture, a company specializing in computer aided design for the mold, and tool and die industry related to the automotive manufacturers. He redirected his career to the medical business as a co-founder of The Windsor Laser Eye Institute. Barazi helped launched ICON Laser Eye Centers Inc. in Canada in 1995. ICON became the fastest growing Lasik Company in the world, boasting more than 40 centers in Europe, Canada, and the USA. Mr. Barazi established a marketing concept around “The War Room” a centralized call center, backed by a web-based driven patient acquisition methodology and value pricing. Mr. Barazi is considered a marketing expert especially in the segment defined as the retail medicine industry.

Nicholas Anthony Havercroft, 45, Director. Mr. Havercroft is a co-founder of the Planet Green Bottle Corporation and has served as its Chairman since 2008. Mr. Havercroft has successfully established and currently operates various large scale farming enterprises, steel manufacturing business, fruit and vegetable importing and tobacco manufacturing businesses.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, ~~as amended,~~ the Registrant has duly caused this ~~report~~Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 23, 2005

Date: June 3, 2010	By:	/s/ Ghassan Barazi

		Ghassan Barazi, President

IMAGIN MOLECULAR CORPORATION

By:/s/ Corey Conn

Corey Conn, Chief Executive Officer

Filing Compare · IMAGIN MOLECULAR CORP